» Practical considerations on the use of TPO-RAs in ITP

This Experts Knowledge Share took place on 11th December, with participants from over 20 countries discussing management of chronic ITP in adults with TPO-RAs, with an expert faculty comprising Dr Hillary Maitland, Dr Michael Tarantino and Dr Vickie McDonald.

The key topics covered in the meetings were:

When to start TPO-RAs and how and where to administer them
Monitoring safety and efficacy
Long-term remission, tapering and adjusting treatment

This programme is supported by an Independent Educational Grant from Sobi.

Dr Vickie McDonald is a consultant haematologist at the Royal London Hospital, London, UK. Her main interests are disorders of coagulation, including ITP. She looks after patients with inherited and acquired disorders of clotting and platelets and runs specialist clinics in ITP. She is an honorary senior lecturer at Queen Mary University of London and is the national chief investigator for the UK ITP registry in addition to the PI and CI for several trials in ITP, both early and late phase studies.

Dr Vickie McDonald has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Abbvie, Amgen, Grifols, Novartis and Sobi.

Dr Hillary Maitland is an Associate Professor of Medicine in the division of Hematology Oncology at the University of Virginia Emily Couric Clinical Cancer Center in Charlottesville Virginia. Her clinical focus is in the treatment of patients with non-malignant hematologic conditions, particularly those with disorders of hemostasis. She leads the hospital’s quality coalition for anticoagulation and thrombosis prevention. Her research focus is on quality and safety of anticoagulant therapies, treatment and prevention of thrombosis.